Corporate Update - Shuttle Pharmaceuticals Holdings, Inc. issued a corporate update on November 13, 2024, in connection with its Quarterly Report for the period ended September 30, 2024[2]. - The press release detailing the financial results is attached as Exhibit 99.1[3]. - The report was signed by CEO Anatoly Dritschilo, indicating leadership's involvement in the financial disclosure[6]. Company Classification - The company is classified as an emerging growth company under the Securities Act of 1933[2]. Financial Performance - The report does not include specific financial performance metrics or user data in the provided content[2][4]. - The company has not provided future outlook or performance guidance in the disclosed content[2][4]. Product and Market Strategy - The company has not indicated any new product launches or technological developments in the available information[2][4]. - There is no mention of market expansion or acquisition strategies in the current report[2][4]. Legal and Filing Status - The filing is not considered "filed" for purposes of the Exchange Act, limiting its legal implications[4]. - The report includes an Interactive Data File as part of its exhibits[5].
Shuttle Pharmaceuticals (SHPH) - 2024 Q3 - Quarterly Results